Baudax Bio, Inc. (BXRX): Price and Financial Metrics

Baudax Bio, Inc. (BXRX): $0.02

0.00 (7.39%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

F

Add BXRX to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#361 of 390

in industry

BXRX Price/Volume Stats

Current price $0.02 52-week high $3.47
Prev. close $0.02 52-week low $0.01
Day low $0.02 Volume 310,800
Day high $0.02 Avg. volume 281,029
50-day MA $0.03 Dividend yield N/A
200-day MA $0.32 Market Cap 1.14M

BXRX Stock Price Chart Interactive Chart >


Baudax Bio, Inc. (BXRX) Company Bio


Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. Its lead product candidate is intravenous form of meloxicam, a non-opioid that has completed Phase III clinical trials for the management of moderate to severe pain; and is in the Phase IIIb clinical trials in colorectal surgery and orthopedic surgery patients to assess opioid consumption, pain intensity, and length of hospital stay with associated pharmacoeconomic parameters. The company's early-stage product candidates includes RP1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; and RP2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and a reversal agent, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.


BXRX Latest News Stream


Event/Time News Detail
Loading, please wait...

BXRX Latest Social Stream


Loading social stream, please wait...

View Full BXRX Social Stream

BXRX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year -69.04%
3-year -100.00%
5-year -100.00%
YTD -9.09%
2023 -99.31%
2022 -98.96%
2021 -78.30%
2020 -85.40%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!